Warfarin Coumadin

  • Uploaded by: E
  • 0
  • 0
  • October 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Warfarin Coumadin as PDF for free.

More details

  • Words: 372
  • Pages: 1
INDEX Generic Name

Trade Name

warfarin

Coumadin

Peak Onset 5-7 days 36-72 hours Why is your patient taking this medication?

NURS 2236 Clinical Form 3: Clinical Medications Worksheet (You will need to made additional copies of these forms) Classification Dose Route Time/Frequency 2.5-10mg PO Daily for 2-4 days then adjust daily dose by results anticoagulants of prothrombin time.

Duration 2-5 days

Mechanism of action and indications Prophylaxis and treatment of Venous thrombosis, pulmonary embolism, atrial fibrilation with embolization, Management of MI's (decreases risk of death, decreases risk of subsequent MI, and decreases risk of future thromboembolic events.) Prevention of thrombus formation and embolization after prosthetic valve placement.

For IV meds, compatability with IV drips and/or solutions

Nursing Implications (what to focus on) Contraindications/warnings/interactions Uncontrolled bleeding, open wounds, active ulcer disease, recent brain, eye, or spinal cord injury, or surgery, severe liver or kidney disease, uncontrolled hypertension, preganancy Use cautiously in: malignancy, patients with history of ulcer or liver disease, history of poor compliance, and women with childbearing potential. Common side effects Cramps, nausea, dermal necrosis, bleeding and fever

Prevention of thromboembolic events Interactions with other patient drugs, OTC, or herbal medicines (ask patient specifically) Abciximab, androgens, capecitabine, cefoperazone, cefotetan, chloral hydrate, chloramphenicol, clopidogrel, disulfiram, fluconazole, fluoroquinolones, itraconazole, metronidazole, thrombolytics, eptifibatid, tirofiban, ticlopidine, sulfonamides, quinidine, quinine, NSAID's, valproates, aspirin, acetaminophen, alcohol, barbiturates, hormonal contraceptives, Nursing Process - Assessment (Pre-administration assessment) Signs of bleeding and hemorrhage (bleeding gums; nosebleed; unusual bruising; tarry, black stool; hematuria; fall in hematocrit or blood pressure; guaiac-positive stools, urine, or nasogastric aspirate. vital signs

Lab value alterations caused by medicine

Be sure to teach the patient the following about this medication Limit intake of Vitamin K foods, avoid IM injections, or activities leading to injury, use soft toothbrush, don't floss, shave with electric razor, venipunctures and injection sites require pressure to prevent bleeding or hematoma formation. Report and sign of bleeding or bruising; Don't dring alcohol or take OTC, especially those containing aspirin; frequent lab test to monitor. Assessment Evaluation Why would you hold or not give Check after giving this med? Prolonged PT (1.3-2.0 times the control; may PT is excessively prolonged or if minor vary with indication) or INR of 2-4.5 without bleeding occurs. signs of hemorrhage.

Related Documents

Warfarin Coumadin
October 2019 17
Coumadin Warfarin
November 2019 14
Coumadin
November 2019 14
Warfarin
June 2020 8
Fax Warfarin
November 2019 10

More Documents from "Christopher Lee"

Zocor
October 2019 31
Albuterol Proventil
October 2019 37
Cymbalta
October 2019 40
Feosol[1]
October 2019 32